4.4 Article

Tripartite motif protein 52 (TRIM52) promoted fibrosis in LX-2 cells through PPM1A-mediated Smad2/3 pathway

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues

Maurizio Parola et al.

MOLECULAR ASPECTS OF MEDICINE (2019)

Article Cell Biology

TRIM72 contributes to cardiac fibrosis via regulating STAT3/Notch-1 signaling

Xu Chen et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Medicine, Research & Experimental

WISP3 prevents fibroblast-myofibroblast transdifferentiation in NRK-49F cells

Yang Yi et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Review Gastroenterology & Hepatology

Hepatic fibrosis: It is time to go with hepatic stellate cell-specific therapeutic targets

Devaraj Ezhilarasan et al.

HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2018)

Review Cell Biology

TGF-/SMAD Pathway and Its Regulation in Hepatic Fibrosis

Fengyun Xu et al.

JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2016)

Review Gastroenterology & Hepatology

Liver fibrosis and hepatic stellate cells: Etiology, pathological hallmarks and therapeutic targets

Chong-Yang Zhang et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2016)

Article Genetics & Heredity

Metabolic characterization of the natural progression of chronic hepatitis B

Johannes C. Schoeman et al.

GENOME MEDICINE (2016)

Review Pathology

Pathogenesis of Liver Fibrosis

Virginia Hernandez-Gea et al.

ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 6 (2011)

Article Gastroenterology & Hepatology

Discriminant value of serum HBV DNA levels as predictors of liver fibrosis in chronic hepatitis B

F. M. Sanai et al.

JOURNAL OF VIRAL HEPATITIS (2011)

Review Biochemistry & Molecular Biology

Activation of hepatic stellate cells - A key issue in liver fibrosis

HL Reeves et al.

FRONTIERS IN BIOSCIENCE-LANDMARK (2002)